• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Survival outcomes in iron chelated and non-chelated patients with lower-risk myelodysplastic syndromes: Review and pooled analysis of observational studies.

作者信息

Abraham Ivo, Yami Majed Al, Yun Seongseok, Kim Hee-Ju, Vincelette Nicole D, McBride Ali, MacDonald Karen

机构信息

Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; University of Arizona Cancer Center, Tucson, AZ, USA; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA; Department of Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA; Matrix45, Tucson, AZ, USA.

Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

出版信息

Leuk Res. 2017 Jun;57:104-108. doi: 10.1016/j.leukres.2017.03.007. Epub 2017 Mar 18.

DOI:10.1016/j.leukres.2017.03.007
PMID:28343141
Abstract
摘要

相似文献

1
Survival outcomes in iron chelated and non-chelated patients with lower-risk myelodysplastic syndromes: Review and pooled analysis of observational studies.低危骨髓增生异常综合征患者接受铁螯合治疗与未接受螯合治疗的生存结局：观察性研究的综述与汇总分析
Leuk Res. 2017 Jun;57:104-108. doi: 10.1016/j.leukres.2017.03.007. Epub 2017 Mar 18.
2
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).定期输血的低危 MDS 患者的螯合疗法是否能提高生存率？GFM（法语国家骨髓增生异常综合征组）的一项多中心研究。
Leuk Res. 2010 Jul;34(7):864-70. doi: 10.1016/j.leukres.2009.12.004. Epub 2010 Feb 2.
3
Iron chelation therapy in MDS: does it improve survival?骨髓增生异常综合征中的铁螯合疗法：能否提高生存率？
Leuk Res. 2010 Jul;34(7):852-3. doi: 10.1016/j.leukres.2010.03.005. Epub 2010 Mar 25.
4
Do Recent Randomized Trial Results Influence which Patients with Myelodysplastic Syndromes Receive Iron Chelation?近期随机临床试验结果是否影响接受铁螯合治疗的骨髓增生异常综合征患者？
Hematol Oncol Clin North Am. 2020 Apr;34(2):465-473. doi: 10.1016/j.hoc.2019.10.006. Epub 2020 Jan 21.
5
[The role of iron metabolism in myelodysplastic syndromes].[铁代谢在骨髓增生异常综合征中的作用]
Recenti Prog Med. 2014 Mar;105(3):123-6. doi: 10.1701/1434.15874.
6
Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.骨髓增生异常综合征及输血性铁过载患者铁螯合治疗指南。
Leuk Res. 2007 Dec;31 Suppl 3:S10-5. doi: 10.1016/S0145-2126(07)70461-7.
7
Iron chelation therapy in low risk myelodysplastic syndrome.低危骨髓增生异常综合征的铁螯合疗法
Br J Haematol. 2017 May;177(3):375-387. doi: 10.1111/bjh.14602. Epub 2017 Mar 16.
8
Iron chelation therapy in myelodysplastic syndrome - Cui bono?骨髓增生异常综合征中的铁螯合疗法——谁将受益？
Leukemia. 2009 Aug;23(8):1373. doi: 10.1038/leu.2009.39.
9
Management of transfusion-related iron overload in patients with myelodysplastic syndromes.骨髓增生异常综合征患者输血相关铁过载的管理
Clin J Oncol Nurs. 2012 Jun;16 Suppl:37-46. doi: 10.1188/12.CJON.S1.37-46.
10
The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome.螯合疗法对输血性铁过载患者生存的影响：骨髓增生异常综合征的荟萃分析
Br J Haematol. 2014 Dec;167(5):720-3. doi: 10.1111/bjh.13053. Epub 2014 Jul 22.